Definium Therapeutics (DFTX) Capital Expenditures (2023 - 2026)
Definium Therapeutics' (DFTX) quarterly Capital Expenditures came in at -$118000.0 in Q1 2026, down 1280.0% year-on-year from $10000.0 in Q1 2025, and down 594.12% on a QoQ basis from -$17000.0 in Q4 2025.
Definium Therapeutics (DFTX) Capital Expenditures (2023 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has 4 years of Capital Expenditures data on file, last reported at -$118000.0 in Q1 2026.
- On a quarterly basis, Capital Expenditures fell 1280.0% year-over-year to -$118000.0 in Q1 2026; TTM through Mar 2026 was -$158000.0, a 664.29% decrease from a year earlier, with the FY2025 full-year figure at -$30000.0, up 37.5% from the prior year.
- Capital Expenditures for Q1 2026 stood at -$118000.0, down from -$17000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for DFTX reached as high as $67000.0 in Q4 2024 and fell as low as -$118000.0 in Q1 2026.
- Historically, Capital Expenditures has averaged -$19000.0 across 4 years, with a median of -$17000.0 in 2023.
- Across the five-year window, Capital Expenditures surged 644.44% in 2024 and plunged 1280.0% in 2026, its largest moves.
- Year by year, Capital Expenditures stood at $9000.0 in 2023, then jumped by 644.44% to $67000.0 in 2024, then slumped by 125.37% to -$17000.0 in 2025, then tumbled by 594.12% to -$118000.0 in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were -$118000.0 in Q1 2026, -$17000.0 in Q4 2025, and -$11000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Definium Therapeutics | 4.47 Bn | 4.47 Bn | - | -118,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -118,000.00 |
| Mar 31, 2026 | -118,000.00 |
| Dec 31, 2025 | -17,000.00 |
| Dec 31, 2025 | -17,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Jun 30, 2025 | -12,000.00 |
| Jun 30, 2025 | -12,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 67,000.00 |
| Dec 31, 2024 | 67,000.00 |
| Sep 30, 2024 | -25,000.00 |
| Sep 30, 2024 | -25,000.00 |
| Jun 30, 2024 | -24,000.00 |
| Jun 30, 2024 | -24,000.00 |
| Mar 31, 2024 | -66,000.00 |
| Mar 31, 2024 | -66,000.00 |
| Dec 31, 2023 | 9,000.00 |
| Dec 31, 2023 | 9,000.00 |